Julia Feige
Schwarzach Im Pongau, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Beyond B Cell Depletion: Adhesion and Activation Network Remodeling During Repeated Intravenous Anti-CD20 Therapy in Multiple Sclerosis.
Journal: Neurology and therapy
Published: February 21, 2026
Repeated iv anti-CD20 treatment in multiple sclerosis: Long-term effects on peripheral immune cell subsets.
Journal: Annals of clinical and translational neurology
Published: October 03, 2023
Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting.
Journal: International journal of molecular sciences
Published: December 19, 2022
Stroke-like presentation of acute toxic leukoencephalopathy due to capecitabine treatment with extensive intramyelinic edema.
Journal: Chronic diseases and translational medicine
Published: December 10, 2022
Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery.
Journal: Neurology international
Published: October 20, 2022
Cladribine Alters Immune Cell Surface Molecules for Adhesion and Costimulation: Further Insights to the Mode of Action in Multiple Sclerosis.
Journal: Cells
Published: October 17, 2021
Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients.
Journal: Frontiers in immunology
Published: June 01, 2021
Long-term peripheral immune cell profiling reveals further targets of oral cladribine in MS.
Journal: Annals of clinical and translational neurology
Published: June 26, 2020
Successful disease control with alemtuzumab in MOG-IgG-associated demyelinating disease with MS-phenotype.
Journal: Multiple sclerosis and related disorders
Published: March 20, 2020
Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats.
Journal: Nutrients
Published: March 01, 2020
Last Updated: 09/26/2026